Liver function tested: new Drug's safety in spotlight
NCT ID NCT04534699
First seen Jan 04, 2026 · Last updated May 17, 2026 · Updated 23 times
Summary
This study looked at how the drug KBP-5074 behaves in people with moderate liver impairment compared to healthy adults. Twelve participants received a single dose, and researchers measured drug levels in the blood and monitored for side effects. The goal was to understand if liver problems change how the drug is processed, which helps guide safe dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trials of Texas (CTT)
San Antonio, Texas, 78229, United States
-
Orlando Clinical Research Center (OCRC)
Orlando, Florida, 32809, United States
-
Texas Liver Institute (TLI)
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.